Literature DB >> 10961715

In vivo selectivity of nonsteroidal antiinflammatory drugs and gastrointestinal ulcers in rats.

O M Laudanno1, J A Cesolari, J Esnarriaga, P San Miguel, O A Bedini.   

Abstract

The aim of the present work was to study in vivo COX-2-COX-1 selectivity of 16 nonsteroidal anti-inflammatory drugs (NSAIDs) in equipotent ulcerogenic doses in two in vivo experimental models. Indomethacin, ibuprofen, nimesulide, aceclofenac, aspirin, sodium diclofenac, meloxicam, naproxene, paracetamol, piroxicam, tenoxicam, nabumetone, ketoprofen, mefenamic acid, etodolac, and ketorolac were administered to female Wistar rats (N = 10 each group). In experiment I, solid food plus subcutaneous NSAIDs were given. In experiment II, NSAIDs were given by oral gavage and in bolus. Macroscopic gastric antral ulcer area (30%) and intestinal erosiva area (295 mm2) in experiment I and necrotic gastric fundus area (65%) and erosive intestinal area (182 mm2), "in vivo" the NSAIDs COX-1 was showed. Neutrofilia assessed in gastric intestinal mucosa where also ibuprofen and paracetamol not given neotrophilic infiltration. In conclusion, COX-2-COX-1 selectivity was demonstrated in vivo with the drugs aceclofenac, nabumetone, meloxicam, nimesulide, and paracetamol.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10961715     DOI: 10.1023/a:1005508120776

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  42 in total

1.  NSAIDs, Cox-2 inhibitors, and the gut.

Authors:  A Bennett; I A Tavares
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

2.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

3.  Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat.

Authors:  A Anthony; R Sim; A P Dhillon; R E Pounder; A J Wakefield
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

4.  Acetylation of prostaglandin synthase by aspirin.

Authors:  G J Roth; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

5.  Human cyclooxygenase-2 cDNA.

Authors:  T Hla; K Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

6.  Indomethacin produces gastric antral ulcers in the refed rat.

Authors:  H Satoh; I Inada; T Hirata; Y Maki
Journal:  Gastroenterology       Date:  1981-10       Impact factor: 22.682

7.  Indomethacin-induced gastric antral ulcers in hamsters.

Authors:  K P Kolbasa; C Lancaster; A S Olafsson; S K Gilbertson; A Robert
Journal:  Gastroenterology       Date:  1988-10       Impact factor: 22.682

8.  Activity of nimesulide on constitutive and inducible cyclooxygenases.

Authors:  I A Tavares; P M Bishai; A Bennett
Journal:  Arzneimittelforschung       Date:  1995-10

9.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01

10.  Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor.

Authors:  K R Gans; W Galbraith; R J Roman; S B Haber; J S Kerr; W K Schmidt; C Smith; W E Hewes; N R Ackerman
Journal:  J Pharmacol Exp Ther       Date:  1990-07       Impact factor: 4.030

View more
  10 in total

1.  Comparative study of anti-inflammatory and ulcerogenic activities of different cyclo-oxygenase inhibitors.

Authors:  Alessandra Gambero; Tagliane Liza Becker; Andréa Silva Zago; Andréa Fermino de Oliveira; José Pedrazzoli
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

2.  Effect of different cyclooxygenase inhibitors on gastric adaptive cytoprotection induced by 20% ethanol.

Authors:  Alessandra Gambero; Marta Maróstica; Tagliane Liza Becker; José Pedrazzoli
Journal:  Dig Dis Sci       Date:  2007-01-17       Impact factor: 3.199

3.  Adverse effects of incorporating ketoprofen into established rodent studies.

Authors:  Tennille K Lamon; Elizabeth J Browder; Farida Sohrabji; Melanie Ihrig
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-07       Impact factor: 1.232

4.  Anti-tumor effect of non-steroidal anti-inflammatory drugs on human ovarian cancers.

Authors:  Bing Xin; Yoshihito Yokoyama; Tatsuhiko Shigeto; Hideki Mizunuma
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

Review 5.  Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide.

Authors:  Urs A Boelsterli
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  A pharmacokinetic comparison of meloxicam and ketoprofen following oral administration to healthy dogs.

Authors:  L Montoya; L Ambros; V Kreil; R Bonafine; G Albarellos; R Hallu; A Soraci
Journal:  Vet Res Commun       Date:  2004-07       Impact factor: 2.459

7.  Anti-inflammatory effect of bioflora probiotic administered orally or subcutaneously with live or dead bacteria.

Authors:  Om Laudanno; L Vasconcelos; J Catalana; Ja Cesolari
Journal:  Dig Dis Sci       Date:  2006-11-02       Impact factor: 3.487

8.  The effects of cyclooxygenase inhibitors on the gastric emptying and small intestine transit in the male rats following traumatic brain injury.

Authors:  Zakieh Keshavarzi; Mohammad Khaksari; Nader Shahrokhi
Journal:  Iran J Basic Med Sci       Date:  2014-06       Impact factor: 2.699

9.  Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation.

Authors:  Salma E El-Habashy; Ahmed N Allam; Amal H El-Kamel
Journal:  Int J Nanomedicine       Date:  2016-05-26

10.  Comparison of Nociceptive Effects of Buprenorphine, Firocoxib, and Meloxicam in a Plantar Incision Model in Sprague-Dawley Rats.

Authors:  Terese E Bennett; Todd J Pavek; Wayne S Schwark; Bhupinder Singh
Journal:  J Am Assoc Lab Anim Sci       Date:  2021-07-15       Impact factor: 1.232

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.